Key facts
- Trulicity is injected under the skin once a week, on the same day each week if you can.
- Trulicity is not an insulin and should not be used as a substitute for insulin.
- Do not stop using Trulicity without talking to your doctor, as your blood sugar levels can increase.
- If you also take a sulphonylurea or insulin, low blood sugar can occur, so test your blood glucose as instructed and your doctor may change your dose of those medicines.
- Stop and seek urgent medical help if you have severe, persistent stomach pain, which could be a sign of acute pancreatitis.
Who should not take dulaglutide
The leaflet says not to take it if any of these apply to you.
- If you are allergic to dulaglutide or any of the other ingredients of this medicine
Check with a doctor or pharmacist first
Tell them before you take it if any of these apply to you.
- You are on dialysis, as this medicine is not recommended
- You have type 1 diabetes, as this medicine may not be right for you
- You have diabetic ketoacidosis (signs include rapid weight loss, feeling or being sick, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat)
- You have severe problems with food digestion or food remaining in your stomach for longer than normal (including gastroparesis)
- You have ever had pancreatitis (inflammation of the pancreas causing severe stomach and back pain that does not go away)
- You are taking a sulphonylurea or insulin, as low blood sugar (hypoglycaemia) can occur and your doctor may need to change your dose of these medicines
Show 3 moreShow fewer
- Tell your doctor if you develop severe problems with your stomach emptying that will not go away (symptoms such as fullness, nausea and/or vomiting have been reported)
- Dehydration can occur when starting treatment, for example with vomiting, nausea and/or diarrhoea, and may lead to a decrease in kidney function, so drink plenty of fluids
- Tell your doctor you are using Trulicity if you are due to have surgery under anaesthesia
How to take dulaglutide
- Inject once a week, at any time of day, with or without meals, on the same day each week if you can. Each pen contains one weekly dose and delivers only one dose.
- Inject under the skin of your stomach area (abdomen) or upper leg (thigh), or upper arm if someone else gives the injection. Choose a different injection site each week.
- Your doctor decides your dose: 0.75 mg once a week when used alone, 1.5 mg once a week with other diabetes medicines, and it may be increased to 3 mg and then 4.5 mg once a week. Children aged 10 years and above start on 0.75 mg once a week and the dose may be increased to 1.5 mg after at least 4 weeks.
- If you forget a dose and there are at least 3 days until your next dose, inject it as soon as possible. If there are less than 3 days, skip it and inject on your regular day. Do not use a double dose.
- Read the Instructions for Use carefully before using the pen.
Side effects
Get medical help straight away
The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.
- Severe allergic reactions (anaphylactic reactions, angioedema), with symptoms such as rashes, itching, rapid swelling of the tissues of the neck, face, mouth or throat, hives and difficulty breathing (Rare)
- Inflamed pancreas (acute pancreatitis), which could cause severe pain in the stomach and back that does not go away (Rare)
- Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting, which could be a sign of acute pancreatitis: stop using the medicine and seek urgent medical help (Rare)
- Bowel obstruction, a severe form of constipation with stomach ache, bloating or vomiting (Not known)
How common each side effect is
Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.
Very common
More than 1 in 10 people
- Feeling sick (nausea)
- Being sick (vomiting)
- Diarrhoea
- Stomach (abdominal) pain
- Low blood sugar (hypoglycaemia) when used with medicines that contain metformin, a sulphonylurea and/or insulin
Common
Up to 1 in 10 people
- Low blood sugar (hypoglycaemia) when used alone, or with both metformin and pioglitazone together, or with an SGLT2 inhibitor with or without metformin
- Feeling less hungry (decreased appetite)
- Indigestion
- Constipation
- Gas (flatulence)
- Bloating of the stomach
- Reflux or heartburn (gastroesophageal reflux disease, GERD)
- Burping
- Feeling tired
- Increased heart rate
Show 1 moreShow fewer
- Slowing of the electrical currents in the heart
Uncommon
Up to 1 in 100 people
- Injection site reactions (e.g. rash or redness)
- Allergic reactions (hypersensitivity) (e.g. swelling, raised itchy skin rash (hives))
- Dehydration, often associated with nausea, vomiting and/or diarrhoea
- Gallstones
- Inflamed gallbladder
- Change in the way food or drink tastes
Rare
Up to 1 in 1,000 people
- Severe allergic reactions (anaphylactic reactions, angioedema)
- Inflamed pancreas (acute pancreatitis)
- A delay in the emptying of the stomach
Not known
The leaflet says how often is not known
- Bowel obstruction
If you get a side effect, you can report it to the regulator through the Yellow Card scheme.
Pregnancy and breastfeeding
It is not known if dulaglutide could harm an unborn child, and Trulicity should not be used during pregnancy. Women who could become pregnant should use contraception during treatment and tell their doctor if they are pregnant or planning a baby. Do not use Trulicity if you are breast-feeding, as it is not known if dulaglutide passes into breast milk.
Taking it with other medicines
The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.
- Any other medicine you are using, have recently used or might use, because Trulicity can slow stomach emptying which could affect other medicines
Where this comes from
Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.
- Product
- Trulicity 3 mg Solution For Injection In Pre-Filled Pen
- Product licence
- PLPI459850713
- Leaflet dated
- Checked against the leaflet
- Automated check
- 26 of 26 side effects matched to the wording of the leaflet
Other makers of dulaglutide publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.
Read the official leaflet Original on the MHRA site How we make these pages